S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 26.68 CNY -3.75% Market Closed
Market Cap: 17.7B CNY
Have any thoughts about
Shandong Pharmaceutical Glass Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shandong Pharmaceutical Glass Co Ltd

Current Assets 6B
Cash & Short-Term Investments 2.8B
Receivables 1.8B
Other Current Assets 1.3B
Non-Current Assets 3.9B
Long-Term Investments 50k
PP&E 3.6B
Intangibles 250.6m
Other Non-Current Assets 38.8m
Current Liabilities 2.1B
Accounts Payable 759m
Accrued Liabilities 93.5m
Short-Term Debt 707m
Other Current Liabilities 518.7m
Non-Current Liabilities 70.7m
Other Non-Current Liabilities 70.7m

Balance Sheet
Shandong Pharmaceutical Glass Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
227
313
1 078
714
717
923
1 010
708
1 160
1 287
Cash
0
0
0
0
0
0
0
708
1 160
1 287
Cash Equivalents
227
313
1 078
714
717
923
1 010
0
0
0
Short-Term Investments
67
85
180
728
788
462
231
307
1 101
1 218
Total Receivables
730
681
690
725
737
739
949
1 203
1 570
1 734
Accounts Receivables
424
391
436
389
384
405
641
764
872
970
Other Receivables
306
290
254
336
353
334
308
439
699
764
Inventory
475
531
512
545
571
679
749
878
1 210
1 055
Other Current Assets
28
22
43
38
179
200
206
239
279
252
Total Current Assets
1 526
1 631
2 503
2 750
2 992
3 003
3 144
3 335
5 321
5 546
PP&E Net
1 160
1 199
1 239
1 287
1 449
1 970
2 244
2 844
3 171
3 482
PP&E Gross
1 160
1 199
1 239
1 287
1 449
1 970
2 244
2 844
3 171
3 482
Accumulated Depreciation
805
877
958
1 025
1 050
1 028
1 101
1 244
1 451
1 743
Intangible Assets
82
89
99
113
153
172
203
198
260
254
Long-Term Investments
26
25
22
0
0
0
0
0
0
0
Other Long-Term Assets
24
29
41
31
29
25
30
32
32
38
Total Assets
2 818
N/A
2 973
+5%
3 904
+31%
4 180
+7%
4 624
+11%
5 170
+12%
5 621
+9%
6 410
+14%
8 784
+37%
9 319
+6%
Liabilities
Accounts Payable
230
315
318
336
385
564
505
722
696
766
Accrued Liabilities
7
18
22
28
43
45
99
69
51
64
Short-Term Debt
358
232
341
381
417
432
490
714
842
696
Other Current Liabilities
98
144
153
154
220
212
211
174
175
201
Total Current Liabilities
693
710
833
900
1 066
1 253
1 306
1 679
1 764
1 727
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Minority Interest
9
9
0
0
0
0
0
0
0
0
Other Liabilities
0
26
27
30
33
50
60
60
59
58
Total Liabilities
702
N/A
744
+6%
861
+16%
930
+8%
1 098
+18%
1 303
+19%
1 366
+5%
1 739
+27%
1 823
+5%
1 784
-2%
Equity
Common Stock
257
257
304
304
425
595
595
595
664
664
Retained Earnings
1 272
1 385
1 535
1 742
2 017
2 359
2 748
3 162
3 611
4 184
Additional Paid In Capital
587
587
1 205
1 205
1 083
913
913
913
2 687
2 687
Total Equity
2 116
N/A
2 229
+5%
3 044
+37%
3 250
+7%
3 526
+8%
3 868
+10%
4 256
+10%
4 670
+10%
6 962
+49%
7 535
+8%
Total Liabilities & Equity
2 818
N/A
2 973
+5%
3 904
+31%
4 180
+7%
4 624
+11%
5 170
+12%
5 621
+9%
6 410
+14%
8 784
+37%
9 319
+6%
Shares Outstanding
Common Shares Outstanding
505
505
595
595
595
595
595
595
664
664

See Also

Discover More